| 08:20-08:40 |
Satellite session 1. (United Imaging Healthcare) |
Hall B (B1F) |
| 08:20-08:40 |
Pioneering Advances in Brain Imaging through uNeuroEXPLORER |
Edwin Leung (UIHA-GSC) |
|
| 09:00-09:20 |
Opening Ceremony |
Hall A (B1F) |
| 09:00-09:10 |
Opening ceremony |
Keon Wook Kang (President, KSNM & ARCCNM) |
| 09:10-09:15 |
Overview of 2024 Annual Meeting of KSNM & ARCCNM |
Ilhan Lim (Scientific program director, KSNM) |
|
| 09:20-10:40 |
Symposium 1. Future of Nuclear Medicine Under New Health Insurance Policies |
Hall A (B1F)
Chair: Young Hoon Ryu (Gangnam Severance Hospital)
Jin Chul Paeng (Seoul National Univ. Hosptial) |
| 09:20-09:50 |
Introduction of the 2nd National Health Insurance Comprehensive Plan(2024~2028) |
Jae-hong Park (Health Insurance Policy Division, MOHW) |
| 09:50-10:05 |
Trend Change of Nuclear Medicine Practice in South Korea |
Jae Seon Eo (Korea Univ. Guro Hospital) |
| 10:05-10:20 |
Law and Regulation Issues in New Nuclear Medicine Practices |
Jin Chul Paeng (Seoul National Univ. Hosptial) |
| 10:20-10:40 |
Discussion |
|
|
| 09:20-10:40 |
Education 1. Physics in nuclear medicine (Interactive) |
Hall B (B1F)
Chair: Sang-Keun Woo (Korea Institute of Radiological and Medical Sciences) |
| 09:20-09:45 |
Current and future nuclear medicine imaging |
Sun Il Kwon (Univ. of California, Davis) |
| 09:45-10:10 |
Introduction to PET tracer kinetic Modeling |
Seongho Seo (Pai Chai Univ.) |
| 10:10-10:35 |
Alpha particle dosimetry |
Dongyoul Lee (Korea Military Academy) |
|
| 09:20-10:40 |
Scientific session 1. Therapy/Oncology (English) |
Hall C (B1F)
Chair: Won Woo Lee (Seoul National Univ. Bundang Hospital)
Hyun Woo Chung (Konkuk Univ. Medical Center) |
| 10:40-11:10 |
Coffee break / Poster / Exhibition |
| 11:10-12:30 |
Plenary Session 1. Large FOV PET/CT scanner |
Hall A (B1F)
Chair: Gi Jeong Cheon (Seoul National Univ. Hospital) |
| 11:10-11:35 |
Total body PET extension the conventional PET clinical application |
Hongcheng Shi (Zhongshan Hospital) |
| 11:35-12:00 |
Total-Body PET – Where are we today? |
Axel Rominger (Universität Bern) |
| 12:00-12:25 |
The Potential of Artificial Intelligence for LAFOV PET |
Kuanggyu Shi (Universität Bern) |
|
| 12:30-12:50 |
Luncheon Symposium 1. Novartis Korea |
Hall A (B1F) |
| 12:30-12:50 |
Current insights on 177Lutetium-PSMA-617 radioligand therapy (PLUVICTO) for metastatic castration-resistant prostate cancer |
Sohyun Park (National Cancer Center) |
|
| 12:30-12:50 |
Luncheon Symposium 2. GE HealthCare |
Hall B (B1F) |
| 12:30-12:50 |
GE HealthCare Molecular Imaging Trend & Vision |
Da Woon Jung (GE HealthCare) |
|
| 12:30-14:00 |
2024 Young Fellow & Resident Forum |
Hall C (B1F) |
| 12:40-14:00 |
2024 Committee Meeting (정기평의원회) |
Hall D (12F) |
| 14:00-15:20 |
Education 2. Updates of Prostate Cancer in the Era of Theranostics |
Hall A (B1F)
Chair: Jin-Sook Ryu (Asan Medical Center) |
| 14:00-14:25 |
The state of arts of treatment against advanced prostate cancer |
Jae Young Joung (National Cancer Center) |
| 14:25-14:50 |
Heavy ion therapy against the prostate cancer |
Chan Woo Wee (Yonsei Univ. College of Medicine) |
| 14:50-15:15 |
Updates of MRI studies in prostate cancer |
Chankyo Kim (Samsung Medical Center) |
|
| 14:00-15:20 |
Symposium 2. Companion or Competitor in Theranostics: Antibody-Drug Conjugates |
Hall B (B1F)
Chair: Won Jun Kang (Yonsei Univ. College of Medicine) |
| 14:00-14:25 |
Perspective on the development of ADC |
Chang-han Lee (Seoul National Univ.) |
| 14:25-14:50 |
The era of ADC: New strategy conquering cancer |
Jyeon Kim (Samsung Medical Center) |
| 14:50-15:15 |
Development of ADC and Radioimmunoconjugates |
Sang Jeon Chung (Sungkyunkwan Univ.) |
|
| 14:00-15:20 |
Education 3. What you have to know to become a competent nuclear medicine physician for the general scans (English) (Interactive) |
Hall C (B1F)
Chair: Joo Hyun O (Seoul St. Mary's Hospital) |
| 14:00-14:30 |
Essential But Seldom Taught Aspects of Renal Scintigraphy |
Chun Ki Kim (Soonchunhyang Univ. Bucheon Hospital) |
| 14:30-15:00 |
Nuclear Medicine in Musculoskeletal System: case-oriented approach |
Sowon Oh (Boramae Medical Center) |
| 15:00-15:20 |
Discussion |
|
|
| 14:00-15:20 |
Joint Session 1. KARA and Nuclear Medicine |
Hall D (12F)
Chair: Sang Eun Kim (President, KARA) |
| 14:00-14:15 |
KARA and Nuclear Medicine: The Old and Best Friends |
Sang Eun Kim (KARA) |
| 14:15-14:40 |
KARA-Initiated Nuclear Medicine R&D Programs |
Han Ki Jang (KARA) |
| 14:40-15:05 |
KARA Strategies for Academia-Industry Collaboration and R&D Commercialization |
Ji Yup Yoo (KARA) |
| 15:05-15:20 |
Discussion |
|
|
| 15:20-15:40 |
Coffee break / Poster / Exhibition |
| 15:40-17:00 |
Joint Session 2. Management for advanced thyroid cancer |
Hall A (B1F)
Chair: Byeong-Cheol Ahn(Kyungpook National Univ. Hospital)
Ji-hoon Kim (Seoul National Univ. Hospital) |
| 15:40-16:05 |
Systemic therapy for advanced thyroid cancer |
Sun Wook Cho (Seoul National Univ. Hospital) |
| 16:05-16:30 |
Current role of Interventional Radiology in advanced thyroid cancer |
Ji-hoon Kim (Seoul National Univ. Hospital) |
| 16:30-16:55 |
Overcoming radioiodine refractoriness in advanced thyroid cancer |
Byeong-Cheol Ahn (Kyungpook National Univ. Hospital) |
|
| 15:40-17:00 |
Scientific session 2. Basic science |
Hall B (B1F)
Chair: Joo Hyun Kang (KIRAMS)
Jinsu Kim (KIRAMS) |
| 15:40-16:40 |
Symposium 3. ARCCNM: the application of clinical trial network in Asia (English) |
Hall C (B1F)
Chair: Keon Wook Kang (Seoul National Univ. Hospital)
Sonya Youngju Park (Yeouido St. Mary's Hospital) |
| 15:40-16:00 |
The experience of clinical trials in Australia |
Sze Ting Lee (Austin Health) |
| 16:00-16:20 |
The experience of clinical trials in Asia supported by IAEA |
Jae Min Jung (Cellbion) |
| 16:20-16:40 |
Panel Discussion |
Patricia Bautista-Penalosa (St. Luke's Medical Center)
Duy Cuong Dang (Hanoi Oncology Hospital)
Sze Ting Lee (Austin Health)
Jae Min Jung (Cellbion)
|
|
| 16:40-17:00 |
ARCCNM General Assembly |
Hall C (B1F) |
| 17:00-17:30 |
Coffee break / Poster / Exhibition Presentation |
|
| 17:30-18:30 |
Presidential Plenary Session: The new horizons of nuclear medicine |
Hall A (B1F)
Chair: Keon Wook Kang (Seoul National Univ. Hospital) |
| 17:30-18:00 |
Evaluating Isotope Production to Meet Clinical Demand |
Cathy Cutler (Brookhaven National Laboratory) |
| 18:00-18:30 |
A New Era of Nuclear Medicine through Science and Technology |
Makoto Hosono (Kindai Univ. Faculty of Medicine) |
|
| 18:30 |
Welcome Reception |
Hall D (12F) |
